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Given the unique context of warzone engagement, which may include chronic threat, multiple and lengthy
deployments, and loss, there is a need to understand whether and to what extent knowledge about PTSD
derived from studies of civilian trauma exposure is generalizeable to the military. This special issue on PTSD
in the military addresses a range of issues and debates related to mental health in military personnel and
combat veterans. This article provides an overview of the issues covered in selected contributions that have
been assembled for a special volume to consider issues unique to the military. Several leading scholars and
military experts have contributed papers regarding: 1) prevalence rates of PTSD and other post-deployment
mental health problems in different NATO countries, 2) the search for biomarkers of PTSD and the potential
applications of such findings, and 3) prevention and intervention approaches for service members and
veterans. The volume includes studies that highlight the divergence in prevalence rates of PTSD and other
post-deployment mental health problems across nations and that discuss potential causes and implications.
Included studies also provide an overview of research conducted in military or Veteran’s Affairs settings, and
overarching reviews of military-wide approaches to research, promotion of resilience, and mental health
interventions in the Unites States and across NATO and allied ISAF partners.
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I
n this issue, we have brought together researchers and
strategic thinkers involved in topics relevant to
military mental health. We address three important
areas: 1) the prevalence rates of posttraumatic stress
disorder (PTSD) and other mental health problems
between nations, 2) the potential identification of biolo-
gical markers of PTSD or other deployment-related
mental health problems, and 3) interventions for mili-
tary personnel and combat veterans. The decision to
compile a special issue focusing on PTSD issues relevant
to the military was catalyzed by a need to examine the
generalizability and relevance of findings from civilian
populations to the military context. The unique nature
of combat and deployment-related trauma, including
lengthy and repeated deployments, chronic threat, and
multiple trauma exposures, may have different biological
and psychological implications compared to civilian
traumas.
Deployment-related PTSD, as well as associated men-
tal health problems (e.g., depression, alcohol and drug
abuse) presents a major challenge to military and veteran
treatment facilities worldwide. The burden associated
with these problems, including human suffering, lost
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& Alexander, 2011; Sabes-Figuera et al., 2012). While
advancements have been made over the past few decades
in understanding and treating symptoms of PTSD, at
the writing of this issue there remain significant gaps
in knowledge and several unresolved issues. As high-
lighted by this issue, there has been fierce disagreement
regarding the prevalence of PTSD following deployment
among different militaries around the world, making it
difficult to fully comprehend the relationship between
combat exposure and the development of mental health
symptoms after deployment. Gains in understanding
biological aspects of PTSD have also been consistently
made, and there is now growing convergence regarding
the major brain, neurochemical and neuroendocrine
systems involved in deployment-related injuries such as
PTSD.
A critical question, however, is whether and to what
extent biological and other aspects of PTSD resulting
from deployment are equivalent to PTSD that occurs in
civilian contexts. Clinical and biological studies of PTSD
tend to focus on commonalities in presentations across
different populations of trauma survivors, while far less
often emphasizing specific consequences of particular
trauma types. A majority of studies include a hetero-
geneous group of persons that meet the diagnostic
criteria for PTSD at the time of study, generally without
consideration of trauma type (e.g., exposure to inter-
personal violence, natural disaster, accident, or combat).
While the focus on similarities among trauma survivors
yields important information, investigations of variation
as a result of trauma type might also bear fruit. There is
also an increasing interest in understanding how char-
acteristics of different combat theatres may contribute to
new and unique clinical presentations.
Although warfare has occurred since early recorded
history, its characteristics have changed dramatically with
the ever increasing complexity of technology (Singh &
Sharma, 2013; Sutherland, 2012). First and foremost,
war between nations is now largely asymmetric. Thus,
opposing nations frequently have unequal military re-
sources with undefined battlefields, where terror tactics
affect civilians and military personnel alike. Advances in
technology have further changed the type of casualties
sustained. The nature of modern warfare no longer
results in the mass battlefield casualties of earlier con-
flicts such as the First and Second World Wars and the
Vietnam War. As more soldiers survive deployment-
related experiences, attention must be paid to the
profound transformations resulting from deployment,
including invisible, psychic wounds.
Those who work with military personnel or veterans are
highly attuned to the ways in which such persons differ
from traumatized civilians. Many who choose military
service, and even many of those who are mandated to serve,
embrace both the larger principals of duty to country and
the day-to-day regimens that result in a deep connection
and loyalty to fellow service members. Warfighters also
receive extensive training and preparation for combat
trauma. Upon return from deployment, even in cases
where the warfighter had been exposed to one or more life-
threatening or horrifying experience and prolonged peri-
ods of threat in malevolent environments, many soldiers
regard the deployment experience as the best and the worst
of times, and some even seek to return to the battlefield.
Obviously, these latter characteristics distinguish combat
veterans from traumatized adult civilians who do not
generally consciously seek to return to the scene of a
trauma, with the exception of members of the emergency
services whose exposures have much in common with
military personnel. The social connections formed to
fellow servicemen are often difficult to break, and the
necessity of severing such connections to return home to
reintegrate to a pre-deployment environment are also quite
challenging, and form an unusual backdrop for PTSD
symptoms.
The question of whether biological and other aspects of
PTSD resulting from deployment are equivalent to civilian
PTSD is particularly important in designing specialized
treatments for service personnel and veterans. At the
current time, treatments for combat-related PTSD guar-
antee neither significant nor sustained improvement.
A substantial proportion of veterans with PTSD and
related mental health conditions receive treatment for
years or even decades. At the same time, despite some
improvements in recent years, many warfighters still
are reluctant to seek care, and face barriers to care and
stigma. The nature of combat, which may involve killing,
witnessing scenes of death and dismemberment, and
difficult split-second decisions, may also distinguish post-
deployment mental health sequelae and require specialized
pre-deployment training, as suggested by Thompson and
Jetly (2014) in this issue, as well as specialized treatments
that address these complex issues.
We have invited colleagues from a wide range of settings
to compile information that is rarely considered in
academic volumes because it is derived from internal
inquiries to help support decision-making within and
between nations. While some of the information obtained
does not follow the same methodology or conventions,
persons who collect data in the context of informing
military operations often have access to information that
is otherwise not easily obtained. It is important to bring
such information to the attention of academics and
clinicians, in addition to more traditional research papers
or clinical case studies. We focus in this issue on research
derived or sponsored by militaries or Veterans Affairs,
and on the extent to which the resultant knowledge is
synergistic with information obtained in parallel from
civilian settings.
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Different rates of PTSD and other mental health
problems between nations: real or illusory?
The first set of papers report findings of epidemiological
studies in different militaries (Hunt, Wessely, Jones, Rona,
& Greenberg, 2014; Taal, Vermetten, Digna, van Schaik, &
Leenstra, 2014; Van Hooff et al., 2014; Zamorski &
Boulos, 2014). These papers show that estimates of the
prevalence of mental health consequences (e.g., PTSD,
suicidality, mild TBI, and other deployment-related con-
ditions) vary drastically both across and within nations.
For example, it can be clearly seen in Hunt et al. (2014) that
the prevalence of reported PTSD is lower in the United
Kingdom armed forces than is reported in countries such
as the United States, Australia, and Canada (Castro, 2014;
Van Hooff et al., 2014; Zamorski & Boulos 2014, all this
issue). It is also clear that different sampling strategies
(including cohort and timeframe), methods and thresholds
for diagnosis, and consideration of additional risk factors,
such as age and combat experiences, yield markedly
different prevalence estimates and make cross-country
comparisons difficult.
Hunt et al. (2014) review the divergent prevalence
findings between the UK and other allied nations and
discuss possible explanations. PTSD rates in British forces
are estimated at roughly 4% in personnel who have
deployed, and 6% in combat troops, and they note high
levels of alcohol abuse and increased rates of violence
among post-deployment UK combat forces. The authors
provide an extensive discussion of factors in addition
to those noted above that may affect UK prevalence
estimates, including differences in combat exposure,
demographics, tour length, troop structure (vs. the US),
the nature and non-anonymity of assessment, and access
to post service universal health care. Zamorski & Boulos
(2014) review all major epidemiological studies of mental
health outcomes before and during the Afghanistan era in
Canadian Armed Forces. The authors note that such
studies are few, with inadequate detail about deployment
experiences. Their review also highlights how different
methods and samples yield strikingly different findings,
even within one country. Canadian estimates of post-
deployment PTSD range from 8 to 20% across studies.
They find that combat exposure is the most important
factor for deployment-related mental health problems.
Van Hooff et al. (2014) describe the design, sampling
strategies, and methodology of an ambitious epidemio-
logical study of the prevalence of mental disorders in the
Australian Defence Force (ADF), the ADF Mental
Health Prevalence and Wellbeing Study (MHPWS).
This investigation represents the first prevalence study
in an entire military population, and includes psychiatric
interviews, a significant improvement over chart review or
self-report data. Findings indicate that 22% of ADF
members had a mental health disorder in the prior
12 months, the most common of which were anxiety
disorders (15%). Taal et al. (2014) analyzed mental health
consumption for the full cohort of enlisted armed forces
in the Netherlands between 2008 and 2010. The authors
note that warfighters reported being reluctant to seek
care, perceived barriers to care and feared the impact of
stigma. Nonetheless, they do find their way to treatment.
Interestingly, there was a five-fold increase in PTSD
diagnoses in the first 2 years following deployment to
Afghanistan, which may be interpreted as reflecting
delays in accessing care, the development of delayed
onset PTSD, or a gradual increase in the interference of
symptoms in everyday life. An important issue raised by
this paper is the extent to which the development of
adequate mental health infrastructures should depend on
the proportion or absolute number of warfighters
affected. The authors suggest that the figures from the
Netherlands do not support the view presented in the
media that military involvement in Afghanistan has led to
an ‘‘epidemic of psychiatric illnesses,’’ but that the
escalating symptoms over a 5-year period justify the
development of a strong mental health infrastructure for
returning soldiers.
In addition to the methodological issues noted above,
it is important to consider potential structural factors
that may influence estimates of post-deployment or
service mental health problems. For example, unlike the
other countries mentioned above, the United Kingdom
does not have a veterans, system of health care. It is
possible that the problem of PTSD in the military might
be less detectible because once individuals leave Defense
in the United Kingdom, their ongoing health care
becomes the responsibility of the National Health
System, and is therefore harder to track as a military-
related problem. It is certainly the case that to the extent
that there are long-term consequences associated with
war, this would represent a major forward liability for any
government to fund, particularly in terms of pensions
and health costs. In cases such as the United Kingdom,
where this cost is hidden within the much larger national
health budget, its relevance and significance is not subject
to actuarial scrutiny, and the burden of military service
may be underestimated.
Thus, epidemiological research on PTSD and other
post-deployment mental health conditions has significant
budgetary and political, as well as scientific, conse-
quences. When reported prevalence rates are low, it is
more difficult to conceptualize post-deployment mental
health symptoms as war wounds, and such findings may
be used as justification for the lack of an integrated
veterans’ health system. Indeed, countries which do not
consider mental health outcomes as a cost of war may
not make appropriate provisions for treatment. Further-
more, such governments are also not accepting liability
associated with having contributed to long-term disability
in troops sent to war. When there is a higher prevalence it
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is easier to conclude that warzone experiences represent
the major causal antecedents or precipitants of illness,
and such findings provide support for investments in
research, prevention, treatment, and longer-term care for
soldiers and veterans.
Despite the major policy, fiscal, and programmatic
implications of prevalence estimates of deployment-
related mental health problems, the significant methodo-
logical differences across studies are seldom highlighted
in the debate surrounding international comparisons of
post-deployment morbidity. Clearly rates are higher in
studies that use anonymous self-report questionnaires
rather than structured interviews, and in investigations
that compare deployed with non-deployed groups (Hoge
et al., 2004). Furthermore, longitudinal studies of the US
military on the impact of deployment, which permit
individuals to act as their own controls, generally do
point to significant rates of morbidity as a consequence
of deployment (Tanielian & Jaycox, 2008). A recent
publication demonstrated that the dramatic differences
in estimates of the psychological burden of combat
between the United States and the United Kingdom
largely disappear once self-reported combat exposure is
taken into account (Sundin et al., 2014).
Biomarkers of PTSD
Given the methodological and structural challenges in
establishing valid prevalence rates that can be compared
across nations, the potential identification of biological
markers of PTSD or other deployment-related mental
health problems offers alternative, objective prevalence
measures. There has been an enormous effort to cap-
ture risk and resilience factors, as well as identify bio-
markers of expressed illness (Yehuda, Neylan, Flory, &
McFarlane, 2013). Three papers in this issue highlight
some of the important developments in identifying
biomarkers of risk and resilience (Daskalakis & Yehuda,
2014; Lehrner & Yehuda, 2014; Neylan, Schacht, Yehuda,
2014). Neylan et al. (2014), review the need to iden-
tify illness biomarkers and the various approaches that
should be used. The development of numerous biological
methods that permit large-scale screening of biomolecules
(genome-wide genotype, epigenetic, gene expression,
and large numbers of proteins and metabolites), as
well as computational advancements, leave the field well
poised to identify biomarkers using discovery-based
approaches. In the past, progress has been impeded by
the necessity of developing elaborate models and narrowly
focusing on specific markers and systems. Hypothesis
generating approaches were previously viewed as expen-
sive ‘‘fishing expeditions’’ that increased the probability
of false positives. However, sophisticated procedures for
computation and validation of discovered biomarkers
have reduced these concerns and heralded a new era,
which promises the delivery of objective biological
indicators of a mental battlefield injury.
While it is universally recognized that modern medi-
cine would be seriously constrained without diagnostic
blood tests, biopsies, and imaging, psychiatry and mental
health have remained largely without objective diagnostic
tests or prognostic indicators. It is important to consider
how the availability of such markers would affect soldiers.
It is reasonable to assume that for many, not having
validation of PTSD as a legitimate war-related injury
fuels the perception that PTSD and other deployment-
related mental injuries are not ‘‘real.’’ The fact that only
some combat soldiers develop PTSD may be seen by
some as a reflection of personal weakness rather than
of the life-altering impact of trauma. This stigma deepens
the abyss between warfighters and the social support
networks crucial to their recovery. The delivery of
objective biological indicators of a mental battlefield
injury, or a test that would facilitate engagement in
treatment early on in the progression of the disease, might
preempt worsening of illness and the deleterious inter-
personal consequences that occur when initial symptoms
are neglected and avoided. Biomarkers that could reflect
fitness for duty following a combat injury would also be
important, by helping the military to make reasonable
policy decisions regarding who is fit to serve even in the
context of past mental health symptoms. This is im-
portant because an overly conservative stance that
prevents further combat exposure ostensibly to protect
combat veterans with prior illness may be stigmatizing
and result in a reluctance to report symptoms. Alterna-
tively, for those that believe they are more impaired than
they in fact may be, an objective measure may provide
information that can allow soldiers to mobilize resilience-
related resources and return to military duty and/or
occupational functioning post-deployment.
In the push to identify PTSD biomarkers, there has
been little discussion of how these markers will be used in
clinical and non-clinical settings, as well as the legal and
ethical implications. Even before troops are deployed,
how will the military use biomarkers to screen, hire,
place, or even reject potential recruits? Once they are
deployed or return from deployment, can biomarkers be
used to diagnose acute or chronic combat-related illnesses
or determine fitness for duty or disability? Lehrner and
Yehuda (2014) discuss how biomarkers might be used in
the context of prediction of risk prior to deployment,
diagnosis, prognosis, and triage in the military. They also
discuss potential unintended consequences of the use of
biomarkers and the need for more engaged dialogue in
the field and with legal and ethics experts.
Daskalakis and Yehuda (2014) discuss the relevance of
animal studies to the identification of combat-related
biomarkers. In animal literature there is a great deal
of attention on the ‘‘nature’’ of the stress exposures.
Rachel Yehuda et al.
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In contrast, in human research relatively little attention is
paid to the highly diverse nature of traumatic experiences,
arguably a critical factor in human variation in response
to trauma exposure. Insofar as animal studies hold
potential to advance our understanding of PTSD, it is
important to consider differences in biological findings
when comparing trauma or stress exposed to non-
exposed animals, versus those that result from examining
individual differences. This paper also makes a contribu-
tion in examining how findings from animal models of
PTSD are critical to advancing efforts in clinical treat-
ment. Ideally, information from blood and brain from
humans and animals, carefully considered in tandem and
possibly even computed simultaneously, can be used to
identify molecules, pathways and networks that are likely
to be the key drivers of PTSD symptoms. With animal
models, and newer biological methodologies, critical genes
and pathways can be tuned up or down (rather than
ablated completely) in discrete brain regions. Such tech-
niques in tandem with human imaging and blood studies
will accelerate the identification of novel pharmacolo-
gical and non-pharmacological intervention strategies.
Interventions for military personnel and combat
veterans
A notable finding in the PTSD treatment outcome
literature has been that randomized clinical trials often
have better outcomes in civilians than in combat veterans
(Bradley, Greene, Russ, Dutra, & Westen, 2005). This
has been demonstrated for both pharmacological and
psychotherapeutic studies. In fact, in industry-sponsored
clinical pharmacological trials conducted in the late 1990s,
combat veterans receiving treatment at US Veterans
Administration (VA) medical centers were excluded be-
cause of the concern that including such patients might
result in falsely negative findings. It remains a question
whether the kind of treatment regimen that has worked
well for civilians is adequate for treating the specific issues
that result from combat exposure. There are also concerns
about the high dropout rates for evidence-based CBT
treatments at the VA, and the small effect sizes noted for
treatment completers with these treatments. As most
specialized therapies for PTSD require engaging with the
trauma memory and associated emotions, it may be
particularly difficult for military veterans to engage in
these treatments given their training on self-discipline, self-
control, and hypervigilance. Furthermore, for veterans
who have experienced loss, guilt, or shame, it is not clear
whether exposure-based therapies are effective. There are
additional outcomes above and beyond those associated
with PTSD that are particularly relevant for warfighters. In
addition to focusing on core PTSD symptoms, it is
appropriate to consider strategies for helping combat
veterans with memory and cognition, ability to function
in school or work, tolerance of affect and emotions in
general, effective parenting, and overall mental and
physical health.
Thompson and Jetly (2014) describe a novel program for
moral dilemma training prior to deployment, which could
help reduce battlefield stressors and ethical lapses. They
propose adjunctive scenario-based ethics training in the
field in support of conventional military ethics training
and education. Such preparation may serve to enhance
psychological resilience and wellbeing during and after
deployment as well as improve the effectiveness of the
military mission. It is particularly important that the
military is aware of the need to provide such training, as
there are often highly ambiguous situations during com-
bat. The recognition that the experience of having parti-
cipated in war*however justified and morally executed*
may create an existential crises is a significant advance.
Ivanov and Yehuda (2014) discuss the challenges to
differential diagnosis posed by comorbid attention deficit
hyperactivity disorder (ADHD) and PTSD symptoms, and
the relevance of ADHD for military service and deploy-
ment. They suggest that ADHD may differentially affect
fitness for service versus deployment, which raises similar
questions about screening, job placement, deployment,
and exposure to potential stressors to those noted above
regarding the use of mental health biomarkers in military
contexts. They also show how the unique neurobiology
of these disorders complicates complementary pharmaco-
logic treatment, as standard treatment for one disorder
(e.g., stimulants for ADHD) may exacerbate the other
(e.g., cause increased anxiety and agitation in PTSD).
Vermetten et al. (2014) provide a novel, broad-ranging,
comparative analysis of approaches to mental health care
across NATO and allied ISAF partners including the
United Kingdom, Canada, Australia, the United States,
and the Netherlands. This group of investigators, all
participants in NATO sponsored panels, discuss issues
that may account for the different prevalence estimates
across and within nations. The review summarizes
ingredients of state-of-the-art preventative mental health
care. To further reduce the prevailing stigma around
mental problems, training for ‘social leadership’ and
‘paraprofessional peer supporters’ were identified as key
important topics across surveyed countries. Both ap-
proaches may speed responses to mental health issues
within the unit, lowering dependency on scarce mental
health professionals.
Castro (2014) provides a bird’s eye view of the US
Department of Defense (DoD) approach to mental
health for veterans of the conflicts in Iraq and Afghani-
stan. This paper describes the DoD’s Psychological
Health Research Continuum, which guides the research
strategy for PTSD, mTBI, and suicide. The Continuum
specifies research that will support ‘‘understanding,
prevention, and intervention,’’ which includes basic
science, epidemiology, etiology, prevention and screening,
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treatment, follow up care, and systems of care. This paper
also reviews issues regarding combat and mental health,
including risk and resilience factors of mental health,
biomarkers of PTSD, mental health training, psycholo-
gical screening, psychological debriefing, third location
decompression, combat and suicide, psychotherapy and
drug therapy for PTSD, the role of advanced technology,
telemedicine and virtual reality, methods to reduce stigma
and barriers to care, and best approaches to disseminate
effective interventions. Finally, a brief review and discus-
sion of the research looking at special populations,
including National Guardsmen and reservists, female
service members, and ethnicity and race, and the military
family is provided.
Conclusion
Much of the knowledge that has accrued regarding the
mental health consequences of war has been generated by
the military, but increased funding has also supported
research in a variety of clinical and academic settings.
Studies documenting the prevalence of PTSD and other
mental health consequences of war have had the most
variable results, and the studies in this issue highlight
some of the implications associated with different re-
ported rates of PTSD following combat.
In parallel with epidemiologic studies documenting the
prevalence of mental health problems, there is an effort
to capture risk and resilience factors, as well as to iden-
tify biomarkers of expressed illness. Such biologically
informed studies may ultimately provide relevant data
regarding prevalence. That is, to the extent that soldiers
can submit to a single blood test that informs their mental
health symptoms, this potentially provides an important
context for interpreting the nature of combat wounds.
Previously, there have been limited resources for exami-
nation of biomarkers as either risk factors or diagnos-
tic markers in the military, but the growing trend is to
investigate biological factors that may inform clinical and
occupational decision-making.
Finally, both epidemiologic and biologic studies are
performed to elaborate the scope and specifics of post-
deployment mental health problems and to promote
prevention and treatment interventions. There are sev-
eral important issues here. The first concerns whether
combat-related mental health consequences are similar to
those associated with other traumatic exposures. For
example, there has been an implicit assumption in the
field that with respect to PTSD, combat is a precipitating
traumatic event similar to other forms of interpersonal
violence. However, in conceptualizing resilience training
and other prophylactic strategies, as well as immediate
and long-term mental health treatment for war veterans,
it is important to be certain whether combat trauma is
similar to other traumatic events that are associated with
an extreme fear response. Understanding some of the
specific demands and moral conflicts of the battlefield
will help direct the field toward more nuanced investiga-
tions into disease risk and etiology and the development
of more specific treatments.
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